Assessment of serotonergic function in major depression using d- fenfluramine: Relation to clinical variables and antidepressant response

Biological Psychiatry

Volumn 44, Issue 7, 1998, Pages 555-561

  Cleare, Anthony J ^a   Murray, Robin M ^a   O'Keane, Veronica ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antidepressants; Cortisol; d fenfluramine; Major depression; Prolactin; Serotonin

Indexed keywords

DESIPRAMINE; DEXFENFLURAMINE; HYDROCORTISONE; IMIPRAMINE; ORG 4428; PROLACTIN; SEROTONIN; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HORMONE RESPONSE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RATING SCALE; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM;

ADULT; AREA UNDER CURVE; DEPRESSIVE DISORDER; FEMALE; FENFLURAMINE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0032191007     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00018-3     Document Type: Article

References (46)

1. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington, DC: American Psychiatric Press.
2. APA Task Force on Laboratory Tests in Psychiatry (1987): The dexamethasone suppression test: An overview of its current status in psychiatry. Am J Psychiatry 144:1253-1262.
3. Asnis GM, Eisenberg J, van Praag HM, Lemus CZ, Friedman JM, Miller AH (1988): The neuroendocrine response to fenfluramine in depressives and normal controls. Biol Psychiatry 24:117-120.
4. Bech P, Rafaelsen OJ (1980): The use of rating scales exemplified by a comparison of the Hamilton and Bech-Rafaelsen melancholia scale. Acta Psychiatria Scand 62(suppl 285): 128-131.
5. Checkley SA (1980): Neuroendocrine tests of monoamine function in man: A review of basic theory and its application to the study of depressive illness. Psychol Med 10:35-53.
6. Cleare AJ, Murray RM, O'Keane V (1996): Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects. Neuropsychopharmacology 14:349-354.
7. Cowen PJ, Power AC, Ware CJ, Anderson IM (1994): 5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone. Br J Psychiatry 164:372-379.
8. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990): Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47:411-418.
9. Delgado PL, Price LH, Miller HL, et al (1994): Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry 51:865-874.
10. Derogatis LR, Melisaratos N (1983): The Brief Symptom Inventory: An introductory report. Psychol Med 13:595-605.
11. Dinan TG (1994): Glucocorticoids and the genesis of depressive illness. A psychobiological model. Br J Psychiatry 164:365-371.
12. Dinan TG (1996): Serotonin and the regulation of hypothalamic-pituitary-adrenal function. Life Sci 58:1683-1694.
13. Feeney S, Goodall E, Silverstone T (1993): The prolactin response to d-and 1-fenfluramine and to d-amphetamine in human subjects. Int Clin Psychopharmacol 8:49-54.
14. Goodall EM, Cowen PJ, Franklin M, Silverstone T (1993): Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacology 112:461-466.
15. Gorard DA, Taylor TM, Medbak SH, Perry LA, Libby GW, Farthing MJ (1993): Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects. Int Clin Psychopharmacol 8:123-128.
16. Hamilton M (1959): The assessment of anxiety status by rating. Br J Med Psychol 32:50-55.
17. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
18. Invernizzi R, Berettera C, Garratini S, Samanin R (1986): D-and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and cathecholamines in the rat. Eur J Pharmacol 120:9-15.
19. Kasper S, Vieira A, Schmidt R, Richter P (1990): Multiple hormone responses to stimulation with dl-fenfluramine in patients with major depression before and after antidepressive treatment. Pharmacopsychiatry 23:76-84.
20. Leatherman ME, Ekstrom RD, Corrigan M, Carson SW, Mason G, Golden RN (1993): Central serotonergic changes following antidepressant treatment: A neuroendocrine assessment. Psychopharmacol Bull 29:149-154.
21. Lewis DA, Sheerman BM (1984): Serotonergic stimulation of adrenocorticotrophin secretion in man. J Clin Endocrinol Metab 58:458-462.
22. Lewis DA, Sherman BM (1985): Serotonergic regulation of prolactin and growth hormone secretion in man. Acta Endocrinol 110:152-157.
23. Lopez Ibor JJ Jr, Saiz Ruiz J, Iglesias LM (1988): The fenfluramine challenge test in the affective spectrum: A possible marker of endogeneity and severity. Pharmacopsychiatry 21:9-14.
24. Maes M, Meltzer HY (1995): The serotonin hypothesis of major depression. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: Fourth Generation of Progress. New York: Raven Press, pp 933-944.
25. Maes M, P DH, Suy E, Minner B, Vandervorst C, Raus J (1991): HPA-axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 15:781-79.
26. Malone KM, Thase ME, Mieczkowski T, et al (1993): Fenfluramine challenge test as a predictor of outcome in major depression. Psychopharmacol Bull 29:155-161.
27. Mann JJ, McBride PA, Malone KM, DeMeo M, Keilp J (1995): Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology 13:53-64.
28. Maskall DD, Zis AP, Lam RW, Clark CM, Kuan AJ (1995): Prolactin response to buspirone challenge in the presence of dopaminergic blockade. Biol Psychiatry 38:235-239.
29. Meltzer HY, Maes M (1995a): Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal men. Biol Psychiatry 38:310-318.
30. Meltzer HY, Maes M (1995b): Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men. Psychiatry Res 58:89-98.
31. Meltzer HY, Umberkoman Wiita B, Robertson A, Tricou BJ, Lowy M, Perline R (1984): Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania. Arch Gen Psychiatry 41:366-374.
32. Mitchell P, Smythe G (1990): Hormonal responses to fenfluramine in depressed and control subjects. J Affect Disord 19:43-51.
33. Moller SE, Bech P, Bjerrum H, et al (1990): Plasma ratio tryptophan/neutral amino acids in relation to clinical response to paroxetine and clomipramine in patients with major depression. J Affect Disord 18:59-66.
34. Montgomery S, Asberg M (1979): A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389.
35. O'Keane V, Dinan TG (1991): Prolactin and cortisol responses to d-fenfluramine in major depression: Evidence for diminished responsivity of central serotonergic function. Am J Psychiatry 148:1009-1015.
36. O'Keane V, O'Hanlon M, Webb M, Dinan T (1991): d-fenfluramine/prolactin response throughout the menstrual cycle: Evidence for an oestrogen-induced alteration. Clin Endocrinol 34:289-292.
37. Palazidou E, Stephenson J, Butler J, Coskeran P, Chambers S, McGregor AM (1995): Evidence for 5-hydroxytryptamine1A receptor involvement in the control of prolactin secretion in man. Psychopharmacology 119:311-314.
38. Park SB, Cowen PJ (1995): Effect of pindolol on the prolactin response to d-fenfluramine. Psychopharmacology 118:471-474.
39. Park SBG, Williamson DJ, Cowen PJ (1995): Do the endocrine and subjective effects of d-fenfluramine predict response to selective serotonin reuptake inhibitors? Int Clin Psychopharmacol 10:215-220.
40. Park SBG, Williamson DJ, Cowne PJ (1996): 5-HT neuroendocrine function in major depression: Prolactin and cortisol responses to D-fenfluramine. Psychol Med 26:1191-1196.
41. Rattle SJ, Purnell DR, Williams PIM, Siddle K, Forrest GC (1984): New separation method for monoclonal immunoradiometric assays for thyrotropin and human choriogonadotropin. Clin Chem 30:1457-1461.
42. Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S (1984): Plasma prolactin changes following fenfluramine in depressed patients compared to controls: An evaluation of central serotonergic responsivity in depression. Life Sci 34: 1029-1039.
43. Van de Kar LD, Karteszi M, Bethea CL, Ganong WF (1985): Serotonergic stimulation of prolactin and corticosterone secretion is mediated by different pathways from the mediobasal hypothalamus. Neuroendocrinology 41:380-384.
44. van Praag HM, Lemus C, Kahn R (1986): The pitfalls of serotonin precursors as challengers in hormonal probes of central serotonin activity. Psychopharmacol Bull 22:565-570.
45. Weizman A, Mark M, Gil Ad I, Tyano S, Laron Z (1988): Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients. Clin Neuropharmacol 11:250-256.
46. Williams J (1988): A structured interview guide for the Hamilton depression rating scale. Arch Gen Psychiatry 45:742-747.